INNOVATION CLINICAL TRIALS (PALMETTO BAY)

•  Females aged 18 and above who:
• Have  an ovarian cyst or adnexal mass identified through imaging examination  (transvaginal ultrasound - TVU) that requires surgery, but have not yet  undergone this surgery
• Have not been diagnosed with ovarian cancer with or without treatment for ovarian cancer
• Have not had both ovaries removed 
• Do not have a prior history of gynecological malignancy (cancer) within last 2 years  
• Do not have a prior history of melanoma (within last 2 years)
• Do not have prior treatment (within 12 months of sample collection) with chemotherapy, radiotherapy, or immunotherapy 
• Are not pregnant and have not been pregnant in the last 3 months 
• Are not immune-compromised. Examples:
• Immune-suppressive conditions (e.g. HIV/AIDS)
• Patients undergoing immunotherapy, chemotherapy, or radiation (within the last 12 months) for any reason
• Patients receiving immune suppressive therapies (e.g. transplant recipients, individuals with known autoimmune disease)
• Patients who have a primary immunodeficiency disorder (e.g. Lupus)
• For more information and to see if you  qualifies, please use the link below

 Are you taking a high sodium oxybate medicine like Xyrem? If so, we are enrolling

Narcolepsy Study
Age Range 18-70 years old
Compensation Up to $1200

First,  sign up with your email address and fill out a questionnaire to find  out whether you pre-qualify for the study. If you are a match and want  to participate, you will need to fill out a Medical Release Consent Form  so we may confirm your Narcolepsy diagnosis with your healthcare  provider(s). We will then walk you through the steps of enrollment and  informed consent process.

The study duration for each participant  will be up to approximately 11 weeks. Participants will attend up to 8  virtual visits. This study will be done virtually, which means we will  come to you to do the study assessments. The study doctor will be  available through telemedicine and a mobile research team member will  come to your home. We will need to evaluate you to see if you qualify  for the study. This evaluation is at no cost to you, and will include a  collection of vitals and an electrocardiogram (ECG).

If qualified,  you can take part in a research study evaluating blood pressure changes  in narcolepsy participants when switching from high-sodium oxybate to a  low-sodium oxybate.

Are you interested in contributing to research on Heart Health?

We are currently searching for volunteers to participate in a research study!

You may be eligible if you:

● Are 22 years of age or older

● Have no history of hypertension (high blood pressure)

Your role in the study:

Wear the study provided watch

Attend 3 virtual study visits

Complete daily home blood pressure monitoring for approximately 4 weeks

Return the study equipment 

Who is a Good Fit for the ACTIV-4b study?

• Between 40 - 80 yrs old
• COVID-19 positive in the last 14 days and is symptomatic
• Not pregnant
• Willing to have a blood test to confirm they can safely join the study
• Willing and able to take study pills every morning and evening for 45 days
• Willing to complete a survey to confirm their study pills were received
• Willing to complete 6 weekly check-ins, along with one call 75 days after starting, so study staff can assure safety and track their progress

7-9 months pregnant or have a baby 14 days old or younger? An infant feeding research study is being conducted for mothers with newborn babies.
Qualified participants may receive:

• Study formula or brand name formula at no cost
• Compensation up to $600 provided for Time. 
• Two months supply of Infant Formula Enfamil
• One month supply of Diapers!  

For more information and to see if your baby qualifies, please contact us

Children aged 6-7 Months are invited to join a Clinical Trial

Your child's participation will assist us in evaluating whether ManACYW conjugate vaccine(the study vaccine) when provided alongside the routine pediatric vaccines, can protect your child against meningococcal disease.Be part of this nationwide clinical study

YOUR CHILD PARTICIPATION CAN MAKE A DIFFERENCE!

For more information and to see if your child qualifies, please contact us

If you are interested in taking part in the RESPRO Study, we’re searching for people who:

• Adults, 18 years of age and older
• Have had a first positive COVID-19 test result within the past 3 days
• Are experiencing mild to moderate COVID-19 symptoms, such as fever, cough, headache or shortness of breath

RESPRO is a clinical research study testing an investigational drug to see whether it could help people with mild to moderate COVID-19 symptoms. 

What is the RESPRO Study?The RESPRO Study is testing an investigational drug to see whether it could help people with mild to moderate COVID-19 symptoms. The investigational drug will be compared with a placebo. A placebo looks exactly like the investigational drug but contains no active ingredients.

Who is taking part in the RESPRO Study?Approximately 668 people in around 100 study centers across the globe are expected to take part in the RESPRO Study.

The Objective of this study is to  collect fresh swab specimens from patients suspect of HSV1, HSV 2 or VZV  infection. Samples will be provided for clinical research; Samples will  not be provided to research outside of this company. 

Eligibility Criteria:

• Ages Eligible: All Ages
• Sexes Eligible:  ALL

Inclusion Criteria:

• Subject  with sign and symptoms suspect of Herpes Simples Virus (HSV) or  Varicella Zoster Virus (VZV), such as skin lesion or rash (Blister,  Macules, papules, ulcers, crusts, and/or  vesicular rash)

The purpose of this study is to assess  the safety and potential efficacy of ZofinTM administered intravenously  in subjects experiencing symptoms consistent with COVID-19 infection  for a prolonged period of time which is greater than 6 weeks  and less than 24 months.

Eligibility Criteria:

• Ages Eligible: ≥ 18 years
• Sexes Eligible:  Female and Male
• COVID-19 survivor who have a documented SARS-CoV-2 positive test 
• Patients who have not fully recovered from COVID-19 for at least over 6 weeks despite a negative SARS-COV-02 test.

A 2-Stage, Adaptive, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate Dose and Treatment Effect of Pentosan Polysulfate Sodium Compare with Placebo in Participants with Knee Osteoarthritis Pain.

Eligibility Criteria:

• Sexes Eligible:  Female and Male
• Radiographic diagnosis of Osteoarthritis of the Knee
• Pain scale of 4 to 10
• BMI ≥18.0 to≤39.0 kg/m2

 How do you Qualify for the Cycloset Pediatric Study?

• Confirm diagnosis of Type 2 Diabetes  (Not Type 1 diabetes)
• 10 to <18 years of age
• Willing to have blood test to confirm they can safely join study
• Willing to take study pills every morning for 24 weeks
• Willing to complete 5 visits in person

Type 2 Diabetes Mellitus is a growing problem with increasing prevalence among pediatric individuals in the US.  VeroScience is currently studying the utility of Cycloset in the treatment of type 2 diabetes mellitus among pediatric patients. 

What is the Cycloset Pediatric Study?

It is a clinical study to evaluate diabetes medication that is approved by the FDA in adults for T2D to see if it would work in the pediatric diabetic population. The study will evaluate how well a drug that is already approved with adults with type 2 diabetes will work in children with type 2 diabetes.  

ACTIV-6 is an at-home clinical study working to find safe treatments for COVID-19. The research study is testing medications that are approved for treating health conditions other than COVID-19 to see if they can help people with mild to moderate COVID-19 feel better faster and stay out of the hospital.

What is This Study About? 

ACTIV-6 is a large clinical research study testing existing prescription and over-the-counter medications for adults with mild-to-moderate COVID-19 symptoms who are not sick enough to be hospitalized. The trial is funded by the National Institutes of Health (NIH).

People can participate from anywhere in the U.S, and medications are shipped at no cost. Participation involves taking the study medication and keeping track of your symptoms and how you feel.

What Medications are Being Studied?

Visit activ6study.org to view the medications that are currently being tested.

Who is Eligible?

You may be eligible if you:

• Are at least 30 years old
• Not in the hospital and tested positive for COVID-19 within the past 10 days
• Have had at least two COVID-19 symptoms for 7 days or less

Why is ACTIV-6 Important?

Results from ACTIV-6 will help researchers understand how existing medications can improve symptoms and limit hospitalizations for people with mild-to-moderate COVID-19.

Call Us For More Information 

786-298-5170